Header cover image

Chinese (SSE) Life Sciences Industry Analysis

UpdatedFeb 03, 2023
DataAggregated Company Financials
Companies23
  • 7D-2.9%
  • 3M9.5%
  • 1Y-4.9%
  • YTD14.1%

Over the last 7 days, the Life Sciences industry has dropped 5.4%, driven by a pullback from WuXi AppTec of 4.4%. The industry has fallen 7.1% in the last year. As for the next few years, earnings are expected to grow by 16% per annum.

Industry Valuation and Performance

Has the Chinese Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 03 Feb 2023CN„691.5bCN„86.6bCN„20.8b58.8x33.2x8x
Sun, 01 Jan 2023CN„604.0bCN„86.6bCN„20.8b50.9x29x7x
Tue, 29 Nov 2022CN„578.2bCN„86.6bCN„20.8b49.5x27.8x6.7x
Thu, 27 Oct 2022CN„573.5bCN„79.5bCN„18.7b52.4x30.7x7.2x
Sat, 24 Sep 2022CN„517.9bCN„77.8bCN„17.0b45.6x30.4x6.7x
Mon, 22 Aug 2022CN„620.5bCN„73.4bCN„17.1b62.3x36.2x8.5x
Wed, 20 Jul 2022CN„711.1bCN„69.0bCN„15.2b70.8x46.9x10.3x
Fri, 17 Jun 2022CN„624.7bCN„69.0bCN„15.2b62.7x41.1x9.1x
Sun, 15 May 2022CN„607.3bCN„68.5bCN„15.1b55.8x40.1x8.9x
Tue, 12 Apr 2022CN„620.5bCN„62.7bCN„15.0b58.6x41.4x9.9x
Thu, 10 Mar 2022CN„566.0bCN„60.9bCN„14.0b59.3x40.3x9.3x
Sat, 05 Feb 2022CN„616.6bCN„57.5bCN„12.3b67.6x50.1x10.7x
Mon, 03 Jan 2022CN„740.4bCN„57.5bCN„12.3b90.4x60.1x12.9x
Wed, 01 Dec 2021CN„876.6bCN„56.9bCN„12.1b97.6x72.2x15.4x
Fri, 29 Oct 2021CN„863.5bCN„55.1bCN„11.8b101.4x73.2x15.7x
Sun, 26 Sep 2021CN„898.9bCN„55.1bCN„12.7b108.3x70.5x16.3x
Tue, 24 Aug 2021CN„911.5bCN„55.1bCN„12.7b98.6x71.5x16.5x
Wed, 30 Jun 2021CN„984.9bCN„53.4bCN„11.5b101x85.6x18.5x
Sat, 03 Apr 2021CN„691.7bCN„44.9bCN„10.4b73.9x66.3x15.4x
Tue, 05 Jan 2021CN„649.8bCN„39.5bCN„7.8b74.9x82.8x16.4x
Fri, 09 Oct 2020CN„513.4bCN„36.6bCN„6.7b82.9x76.4x14x
Thu, 02 Jul 2020CN„481.9bCN„34.2bCN„6.3b89.8x76.9x14.1x
Sun, 05 Apr 2020CN„291.3bCN„32.3bCN„4.4b59.9x65.7x9x
Price to Earnings Ratio

69x


Total Market Cap: CN„305.4bTotal Earnings: CN„4.4bTotal Revenue: CN„32.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Chinese Life Sciences Industry Price to Earnings3Y Average 63.5x202120222023
Current Industry PE
  • Investors are pessimistic on the Chinese Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 32.4x which is lower than its 3-year average PE of 63.5x.
  • The 3-year average PS ratio of 12.8x is higher than the industry's current PS ratio of 7.8x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have grown 67% per year over the last three years.
  • Revenues for these companies have grown 39% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Chinese Healthcare industry?

CN Market1.47%
Healthcare-0.031%
Life Sciences-2.88%
Clinical Research and Equipment-2.88%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
688238 Obio Technology (Shanghai)CN„24.325.3%
+CN„601.7m
n/aPE202.9x
301230 PharmaResources (Shanghai)CN„67.5810.2%
+CN„480.5m
n/aPE72.5x
688222 HitGenCN„16.005.8%
+CN„352.6m
-15.3%PE145.3x
688265 Shanghai Model Organisms CenterCN„56.506.0%
+CN„251.0m
-5.9%PE147.2x
300813 Zhejiang Tailin BioEngineeringLtdCN„45.794.5%
+CN„164.7m
4.7%PE55.7x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

603127

CN„63.21

Joinn Laboratories(China)Co.Ltd

7D

-4.8%

1Y

-8.7%

603259

CN„93.80

WuXi AppTec

7D

-3.8%

1Y

-10.5%

300759

CN„74.72

Pharmaron Beijing

7D

-9.6%

1Y

-5.2%

688114

CN„117.26

MGI Tech

7D

-2.4%

1Y

n/a

300347

CN„118.50

Hangzhou Tigermed Consulting

7D

-4.0%

1Y

14.7%

688238

CN„24.32

Obio Technology (Shanghai)

7D

5.3%

1Y

n/a

688315

CN„33.90

Novogene

7D

-5.8%

1Y

-4.9%

301257

CN„61.18

SMO ClinPlusLTD

7D

3.7%

1Y

n/a

688222

CN„16.00

HitGen

7D

5.8%

1Y

-15.3%

300813

CN„45.79

Zhejiang Tailin BioEngineeringLtd

7D

4.5%

1Y

4.7%

688202

CN„208.27

Shanghai Medicilon

7D

-10.3%

1Y

-18.1%

688046

CN„29.57

GemPharmatech

7D

-2.2%

1Y

n/a

300463

CN„18.77

Maccura BiotechnologyLtd

7D

1.1%

1Y

-24.7%

300404

CN„8.28

Boji Medical Technology

7D

2.5%

1Y

1.2%

688265

CN„56.50

Shanghai Model Organisms Center

7D

6.0%

1Y

-5.9%